China Resources Medical Holdings 将来の成長

Future 基準チェック /36

China Resources Medical Holdings利益と収益がそれぞれ年間31.9%と5%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に12% 35.2%なると予測されています。

主要情報

31.9%

収益成長率

35.2%

EPS成長率

Healthcare 収益成長	18.5%
収益成長率	5.0%
将来の株主資本利益率	12.0%
アナリストカバレッジ	Good
最終更新日	04 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

SZSC:1515 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	11,341	886	N/A	1,387	4
12/31/2025	10,908	792	1,213	1,511	6
12/31/2024	10,421	711	984	1,235	6
6/30/2024	9,970	294	621	1,162	N/A
3/31/2024	10,039	276	665	1,179	N/A
12/31/2023	10,108	258	708	1,195	N/A
9/30/2023	9,958	338	732	1,251	N/A
6/30/2023	9,809	419	756	1,307	N/A
3/31/2023	8,855	342	577	1,086	N/A
12/31/2022	7,901	266	397	864	N/A
9/30/2022	6,891	365	422	772	N/A
6/30/2022	5,881	463	447	680	N/A
3/31/2022	5,164	441	479	695	N/A
12/31/2021	4,447	418	512	710	N/A
9/30/2021	4,031	410	392	628	N/A
6/30/2021	3,615	402	271	546	N/A
3/31/2021	3,183	356	349	595	N/A
12/31/2020	2,751	310	426	644	N/A
9/30/2020	2,404	313	483	614	N/A
6/30/2020	2,058	315	540	584	N/A
3/31/2020	2,087	353	435	475	N/A
12/31/2019	2,115	391	330	366	N/A
9/30/2019	2,112	401	263	300	N/A
6/30/2019	2,108	412	196	234	N/A
3/31/2019	2,084	421	236	284	N/A
12/31/2018	2,059	431	277	334	N/A
9/30/2018	1,996	364	317	371	N/A
6/30/2018	1,932	298	357	407	N/A
3/31/2018	1,905	360	N/A	433	N/A
12/31/2017	1,878	421	N/A	460	N/A
9/30/2017	1,784	-446	N/A	377	N/A
6/30/2017	1,690	-1,312	N/A	294	N/A
3/31/2017	1,611	-1,410	N/A	259	N/A
12/31/2016	1,533	-1,507	N/A	224	N/A
9/30/2016	1,504	-656	N/A	227	N/A
6/30/2016	1,475	196	N/A	230	N/A
3/31/2016	1,424	181	N/A	231	N/A
12/31/2015	1,372	167	N/A	232	N/A
9/30/2015	1,337	208	N/A	246	N/A
6/30/2015	1,302	249	N/A	261	N/A
3/31/2015	1,254	240	N/A	268	N/A
12/31/2014	1,206	230	N/A	274	N/A
9/30/2014	1,090	176	N/A	238	N/A
6/30/2014	975	122	N/A	202	N/A
3/31/2014	931	106	N/A	186	N/A
12/31/2013	887	90	N/A	170	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 1515の予測収益成長率 (年間31.9% ) は貯蓄率 ( 2.3% ) を上回っています。

収益対市場: 1515の収益 ( 31.9% ) はHong Kong市場 ( 11.6% ) よりも速いペースで成長すると予測されています。

高成長収益: 1515の収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: 1515の収益 ( 5% ) Hong Kong市場 ( 7.8% ) よりも低い成長が予測されています。

高い収益成長: 1515の収益 ( 5% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 1515の自己資本利益率は、3年後には低くなると予測されています ( 12 %)。

China Resources Medical Holdings 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

China Resources Medical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2021

Recent updates

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 19%

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

New minor risk - Profit margin trend

Upcoming dividend of HK$0.055 per share

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

China Resources Medical Holdings Company Limited Announces Interim (Semi-Annual) for the Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 25, 2024

China Resources Medical Holdings Company Limited Announces Interim (Semi-Annual) for the Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 25, 2024

China Resources Medical Holdings Company Limited to Report First Half, 2024 Results on Aug 26, 2024

Now 21% undervalued after recent price drop

China Resources Medical Holdings Company Limited Approves the Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024

Upcoming dividend of CN¥0.06 per share

Independent Non-Executive Director recently sold HK$2.6m worth of stock

Dividend of CN¥0.06 announced

China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024

China Resources Medical Holdings Company Limited, Annual General Meeting, Jun 05, 2024

Full year 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.11 in FY 2022)

Now 24% undervalued after recent price drop

China Resources Medical Holdings Company Limited to Report Fiscal Year 2023 Results on Mar 19, 2024

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

China Resources Medical Holdings Company Limited Announces Board and Committee Changes

First half 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.16 in 1H 2022)

China Resources Medical Holdings Company Limited to Report First Half, 2023 Results on Aug 22, 2023

Investor sentiment deteriorates as stock falls 15%

China Resources Medical Holdings Company Limited Announces Board Changes

China Resources Medical Holdings Company Limited Approves Final Dividend for the Year Ended December 31, 2022, Payable on July 19, 2023

Upcoming dividend of HK$0.037 per share at 0.6% yield

Full year 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.33 in FY 2021)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

China Resources Medical Holdings Company Limited Announces Board Changes

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.16 in 1H 2021)

China Resources Medical Holdings Company Limited to Report First Half, 2022 Results on Aug 23, 2022

Investor sentiment improved over the past week

China Resources Medical Holdings Company Limited Declares A Final Dividend for the Year Ended December 31, 2021

China Resources Medical Holdings Company Limited Declares A Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.12 per share

Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.25 in FY 2020)

Less than half of directors are independent

China Resources Medical Holdings Company Limited Proposes Final Dividend for Fiscal Year 2021, Payable on or Before July 19, 2022

Investor sentiment improved over the past week

China Resources Medical Holdings Company Limited to Report Fiscal Year 2021 Results on Mar 25, 2022

China Resources Medical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2021

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.086 in 1H 2020)

Non-Executive Director Yan Wang has left the company

Independent Non-Executive Director recently sold HK$4.7m worth of stock

Investor sentiment improved over the past week

Upcoming dividend of HK$0.088 per share

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.31 in FY 2019)

China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended December 31, 2020

Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.31 in FY 2019)

China Resources Medical Holdings Company Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

New 90-day high: HK$7.35

New 90-day high: HK$6.83

New 90-day high: HK$6.00

New 90-day high: HK$5.69

New 90-day low: HK$4.63

First half earnings released

First half earnings released

New 90-day high - HK$5.81

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘